Brought to you by 
Inverness Medical Technology nets $82.9mm in FOPO
16 Feb 2001
Executive Summary
Inverness Medical Technology (glucose monitoring devices) netted about $82.9mm in a follow-on public offering of 3.5mm common shares, including the 150k share over-allotment, priced at $25 each. Selling shareholders are also offering 250k shares.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
Medical Devices
- Diagnostic Equipment & Supplies
-
In Vitro Diagnostics
- Glucose Testing
Deal Status
- Final
Deal Type
-
Financing
- FOPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Inverness Medical Technology nets $82.9mm in FOPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice